Lluís Ramió‐Torrentà

Author

Institut d'Investigació Biomèdica de Girona ORCID

Also Known As

L Ramio-Torrenta, L Ramió-Torrenta, L Ramió-Torrentà, L. Ramió-Torrentà, L. Ramió-Torrentà, L. Ramió-Torrentá, LLuis Ramió-Torrentà, Ll Ramio-Torrenta, Ll. Ramió-Torrentà, Lluis Ramio-Torrenta

167

Publications

5.8K

Citations

H-Index

103

Concepts

All Affiliations

Institut d'Investigació Biomèdica de Girona Universitat de Girona Hospital Universitari de Girona Doctor Josep Trueta Vall d'Hebron Hospital Universitari Clínica Girona

About

Lluís Ramió‐Torrentà is an author at Institut d'Investigació Biomèdica de Girona specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	2.4K
2	Engineering	7	7	653
3	Health Sciences	3	3	121
4	Public Health	2	2	83
5	Social Sciences	2	2	176

Lluís Ramió‐Torrentà

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association Albert Saiz, Yolanda Blanco, Lídia Sabater, Brain Neurological DisorderCorticobasal DegenerationPathologyNeurochemical BiomarkersNeurological Syndromes	2008	604
Improving automated multiple sclerosis lesion segmentation with a cascaded 3D convolutional neural network approach Sergi Valverde, Mariano Cabezas, Eloy Roura, NeuroImage Cascaded 3DConvolutional Neural NetworkImage AnalysisEngineeringMedical Imaging	2017	381
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease Romana Höftberger, María Sepúlveda, Thaís Armangué, Multiple Sclerosis Journal	2014	276
Microbiota alterations in proline metabolism impact depression Jordi Mayneris‐Perxachs, Anna Castells‐Nobau, María Arnoriaga‐Rodríguez, Cell Metabolism DysbiosisProbioticGut-organ AxisIntestinal MicrobiotaPsychiatry	2022	201
Plasma exchange for acute attacks of CNS demyelination Sara Llufriú, Joaquim Castilló, Yolanda Blanco, Neurology	2009	189
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial Daniel S. Reich, Douglas L. Arnold, Patrick Vermersch, The Lancet Neurology Neurological DisorderPhase 2BClinical TrialsPlacebo-controlled TrialPharmacotherapy	2021	177
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome Clara Matute‐Blanch, Luisa María Villar, José C. Álvarez‐Cermeño, Brain Isolated SyndromeNeurological DisorderPathologyNeurophysiological BiomarkersNeurochemical Biomarkers	2018	158
One-shot domain adaptation in multiple sclerosis lesion segmentation using convolutional neural networks Sergi Valverde, Mostafa Salem, Mariano Cabezas, LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)	2019	154
Obesity Impairs Short-Term and Working Memory through Gut Microbial Metabolism of Aromatic Amino Acids María Arnoriaga‐Rodríguez, Jordi Mayneris‐Perxachs, Aurelijus Burokas, Cell Metabolism ObesityNutritionEnergy HomeostasisDysbiosisMedicine	2020	151
Neuromyelitis optica spectrum disorders María Sepúlveda, Thaís Armangué, Núria Solà‐Valls, Neurology Neuroimmunology & Neuroinflammation	2016	148

Page 1